These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Bioavailability investigation of two different oral formulations of doxepin. Geister U, Gaupp M, Arnold P, Schaarschmidt D, Doser K, Renner J. Arzneimittelforschung; 2001 Apr 10; 51(3):189-96. PubMed ID: 11304934 [Abstract] [Full Text] [Related]
11. A preliminary investigation on the distribution of cannabinoids in man. Gronewold A, Skopp G. Forensic Sci Int; 2011 Jul 15; 210(1-3):e7-e11. PubMed ID: 21570784 [Abstract] [Full Text] [Related]
12. Highly sensitive LC-MS/MS method to estimate doxepin and its metabolite nordoxepin in human plasma for a bioequivalence study. Patel NP, Sanyal M, Sharma N, Patel DS, Shrivastav PS, Patel BN. J Pharm Anal; 2018 Dec 15; 8(6):378-385. PubMed ID: 30595944 [Abstract] [Full Text] [Related]
13. Postmortem distribution/redistribution of buformin in body fluids and solid tissues in an autopsy case using liquid chromatography-tandem mass spectrometry with QuEChERS extraction method. Wurita A, Hasegawa K, Nozawa H, Yamagishi I, Minakata K, Watanabe K, Suzuki O. Forensic Sci Int; 2020 Sep 15; 314():110376. PubMed ID: 32615395 [Abstract] [Full Text] [Related]
14. Pharmacokinetic evaluation of two doxepin products. Wecker MT, Woodworth JR, Amsel LP, Hinsvark ON, Rotenberg KS. Clin Ther; 1986 Sep 15; 8(3):342-7. PubMed ID: 3719617 [Abstract] [Full Text] [Related]